Platelet-rich plasma (PRP) in oncological patients: long-term oncological outcome analysis of the treatment of subcutaneous venous access device scars in 89 breast cancer patients

PURPOSE: Platelet-rich plasma (PRP) is widely used product, and meta-analyses showed this product to be beneficial when applied to a wound area. This study group has already demonstrated increased patient satisfaction and lower complication rates in breast cancer patients who received PRP after remo...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichler, Christian, Üner, Jens, Thangarajah, Fabinshy, Radosa, Julia, Zinser, Max, Fischer, Lotta Ada, Puppe, Julian, Warm, Matthias, Malter, Wolfram, Lenz, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470624/
https://www.ncbi.nlm.nih.gov/pubmed/35377044
http://dx.doi.org/10.1007/s00404-022-06416-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470624/
https://www.ncbi.nlm.nih.gov/pubmed/35377044
http://dx.doi.org/10.1007/s00404-022-06416-4

Ejemplares similares